A. L. Rossina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
A. L. Rossina has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- S. B. Chuyelov
Pirogov Russian National Research Medical University
23 shared publications - Olga V. Shamsheva
Pirogov Russian National Research Medical University
11 shared publications - Natalia V. Kondratenko
Speransky Children's City Clinical Hospital No. 9
6 shared publications - A. A. Korsunskiy
Pirogov Russian National Research Medical University
4 shared publications - Mukhammad A. Sayfullin
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
4 shared publications - A. N. Slatetskaya
Russian Children's Clinical Hospital — Branch of N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
3 shared publications
Latest Publications
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
A modern approach to the problem of congenital rubella syndrome: why it is important to remain vigilant
Congenital rubella syndrome (ICD-10: P35.0) is a symptom complex characterized by the formation of multiple congenital malformations in newborns with perinatal rubella exposure. Despite the fact that rubella virus infection is a vaccine-preventable disease, high migration rates, reduced vaccination rates in certain regions, and irregular prenatal check-ups pose a threat to the spread of rubella infection. The development of preconception preparation protocols with mandatory vaccination of rubella-seronegative women, as well as a clearly implemented algorithm for monitoring pregnant women in all regions, are the main directions for the prevention of congenital rubella syndrome. The article reflects some features of the epidemiological situation regarding rubella, using the example of four cases with perinatal contact with rubella infection who were hospitalized in a children’s multidisciplinary hospital.
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
A modern approach to the problem of congenital rubella syndrome: why it is important to remain vigilant
Congenital rubella syndrome (ICD-10: P35.0) is a symptom complex characterized by the formation of multiple congenital malformations in newborns with perinatal rubella exposure. Despite the fact that rubella virus infection is a vaccine-preventable disease, high migration rates, reduced vaccination rates in certain regions, and irregular prenatal check-ups pose a threat to the spread of rubella infection. The development of preconception preparation protocols with mandatory vaccination of rubella-seronegative women, as well as a clearly implemented algorithm for monitoring pregnant women in all regions, are the main directions for the prevention of congenital rubella syndrome. The article reflects some features of the epidemiological situation regarding rubella, using the example of four cases with perinatal contact with rubella infection who were hospitalized in a children’s multidisciplinary hospital.
- 27 March 2026
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 25 (1)
Imported Opisthorchiasis in Moscow and a substantiation of an alternative concept for the hematogenous migration of Opisthorchis larvaе
The relevance of opisthorchiasis is due to its widespread prevalence in the wild in Russia and its ability to infect humans through the consumption of improperly cooked fish. The aim of this paper is to present available literature data on the epidemiology, clinical and laboratory manifestations, and diagnosis of opisthorchiasis, illustrated by a clinical example. This paper also presents an alternative theory for the hematogenous path of parasite migration in the definitive host. Materials and Methods : A review of recent Russian and international literature, including online resources, was conducted on the situation with opisthorchiasis in Russia and Moscow, as well as the pathogenesis of opisthorchiasis. A clinical observation of a patient with imported opisthorchiasis in Moscow was presented. Conclusion . The diagnosis of opisthorchiasis is based on the epidemiological history, clinical presentation, eosinophilia, and detection of multiple inflammatory foci in the liver. This diagnosis is confirmed by coproovoscopic and serological methods. Focal changes in the liver parenchyma can be explained by the hematogenous migration of opisthorchis larvae.
- 27 March 2026
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 25 (1)
Imported Opisthorchiasis in Moscow and a substantiation of an alternative concept for the hematogenous migration of Opisthorchis larvaе
The relevance of opisthorchiasis is due to its widespread prevalence in the wild in Russia and its ability to infect humans through the consumption of improperly cooked fish. The aim of this paper is to present available literature data on the epidemiology, clinical and laboratory manifestations, and diagnosis of opisthorchiasis, illustrated by a clinical example. This paper also presents an alternative theory for the hematogenous path of parasite migration in the definitive host. Materials and Methods : A review of recent Russian and international literature, including online resources, was conducted on the situation with opisthorchiasis in Russia and Moscow, as well as the pathogenesis of opisthorchiasis. A clinical observation of a patient with imported opisthorchiasis in Moscow was presented. Conclusion . The diagnosis of opisthorchiasis is based on the epidemiological history, clinical presentation, eosinophilia, and detection of multiple inflammatory foci in the liver. This diagnosis is confirmed by coproovoscopic and serological methods. Focal changes in the liver parenchyma can be explained by the hematogenous migration of opisthorchis larvae.
- Open Access
- 25 June 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (2) , 10-15
Serological Profile of COVID-19 in Children with Comorbidities during Omicron Variant Circulation
Тhe characteristics of the humoral immune response to SARS-CoV-2 in children, particularly those with comorbid conditions, remain incompletely understood. The observed variability in antibody production and the sensitivity of serological assays complicate the objective assessment of seroconversion in the pediatric population.Objective: To determine the qualitative and quantitative profiles of IgM and IgG antibodies against SARS-CoV-2 in children with somatic comorbidities during the acute phase of COVID-19 amid the circulation of the Omicron variant.Materials and Methods: A prospective, single-center, non-randomized cohort study was conducted involving hospitalized children with confirmed COVID-19 and underlying chronic conditions. Serological testing was performed on days 1, 8, and 14 of illness using enzyme-linked immunosorbent assay (ELISA) and immunochemiluminescence assay (ICLA) to measure IgM and IgG levels.Results: A total of 99 children with comorbidities were included in the analysis. The seropositivity rate for IgM remained low at all time points (up to 26.3% on day 14). IgG antibodies were detected in the majority of patients as early as day 1, with ELISA demonstrating higher sensitivity (77.6%) compared to ICLA (60%), peak IgG levels were observed on day 8, followed by a significant decline by day 14 (p < 0.01). Children with respiratory system diseases exhibited statistically higher IgG levels compared to those with hemoblastoses, solid tumors, primary immunodeficiencies, and nervous system disorders.Conclusions: Serological diagnosis of COVID-19 in children with comorbidities requires careful consideration of the testing method, disease timeline, and type of underlying somatic pathology. IgG antibodies serve as a more informative marker than IgM, with ELISA offering superior sensitivity.
- 25 June 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (2) , 10-15
Open AccessSerological Profile of COVID-19 in Children with Comorbidities during Omicron Variant Circulation
Тhe characteristics of the humoral immune response to SARS-CoV-2 in children, particularly those with comorbid conditions, remain incompletely understood. The observed variability in antibody production and the sensitivity of serological assays complicate the objective assessment of seroconversion in the pediatric population.Objective: To determine the qualitative and quantitative profiles of IgM and IgG antibodies against SARS-CoV-2 in children with somatic comorbidities during the acute phase of COVID-19 amid the circulation of the Omicron variant.Materials and Methods: A prospective, single-center, non-randomized cohort study was conducted involving hospitalized children with confirmed COVID-19 and underlying chronic conditions. Serological testing was performed on days 1, 8, and 14 of illness using enzyme-linked immunosorbent assay (ELISA) and immunochemiluminescence assay (ICLA) to measure IgM and IgG levels.Results: A total of 99 children with comorbidities were included in the analysis. The seropositivity rate for IgM remained low at all time points (up to 26.3% on day 14). IgG antibodies were detected in the majority of patients as early as day 1, with ELISA demonstrating higher sensitivity (77.6%) compared to ICLA (60%), peak IgG levels were observed on day 8, followed by a significant decline by day 14 (p < 0.01). Children with respiratory system diseases exhibited statistically higher IgG levels compared to those with hemoblastoses, solid tumors, primary immunodeficiencies, and nervous system disorders.Conclusions: Serological diagnosis of COVID-19 in children with comorbidities requires careful consideration of the testing method, disease timeline, and type of underlying somatic pathology. IgG antibodies serve as a more informative marker than IgM, with ELISA offering superior sensitivity.
- Open Access
- 21 March 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (1) , 33-36
Whooping cough in newborns
The relevance of the problem of whooping cough in newborns is due to the severity of clinical manifestations and high mortality.The aim of the work is to present the data available in the literature on the causes of the unfavorable course of whooping cough in newborns, illustrated by our own clinical examples, as well as to summarize the ways to solve this problem.Materials and methods: a review of domestic and foreign literature over the past 10 years, including Internet resources, was conducted and our own clinical observations of newborns with whooping cough are presented.Conclusion. Whooping cough in newborns and children of the first months of life develops due to the absence of maternal anti-whooping cough antibodies. The disease is often severe, ending in death. Prevention of whooping cough in newborns and infants should include mandatory vaccination of pregnant women in the 2nd or 3rd trimester of pregnancy.
- 21 March 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (1) , 33-36
Open AccessWhooping cough in newborns
The relevance of the problem of whooping cough in newborns is due to the severity of clinical manifestations and high mortality.The aim of the work is to present the data available in the literature on the causes of the unfavorable course of whooping cough in newborns, illustrated by our own clinical examples, as well as to summarize the ways to solve this problem.Materials and methods: a review of domestic and foreign literature over the past 10 years, including Internet resources, was conducted and our own clinical observations of newborns with whooping cough are presented.Conclusion. Whooping cough in newborns and children of the first months of life develops due to the absence of maternal anti-whooping cough antibodies. The disease is often severe, ending in death. Prevention of whooping cough in newborns and infants should include mandatory vaccination of pregnant women in the 2nd or 3rd trimester of pregnancy.
- Open Access
- 17 January 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 21-31
COVID-19 in children with chronic digestive system pathology
COVID-19 in children is characterized by a predominance of mild and asymptomatic forms, along with frequent gastrointestinal symptoms. It is known that comorbid conditions are a risk factor for severe COVID-19 in children; however, the course of SARS-CoV-2 infection in children with chronic digestive system diseases remains under-researched. Objective. To identify the specific characteristics of COVID-19 in children with chronic digestive system diseases, assess risk factors for severe COVID-19, and evaluate the impact of immunosuppressive therapy on COVID-19 outcomes. Materials and Methods. A single-center cohort retrospective and prospective non-randomized study was conducted, including 74 patients with COVID-19 and chronic digestive system diseases and a control group of 30 patients with COVID-19 without comorbidities, all hospitalized in the infectious disease department of the Russian Children’s Clinical Hospital, Moscow, in 2022 and 2023. Results. Сhildren with underlying digestive system diseases were not at a higher risk of severe COVID-19 compared to the control group. Severe, uncontrolled somatic disease and the presence of two or more comorbidities were risk factors for complicated SARS-CoV-2 infection. The duration of detectable SARS-CoV-2 RNA in the study group was nine days. Conclusion. Patients with chronic digestive system diseases, including those receiving immunosuppressive therapy, do not appear to be at higher risk for severe or unfavorable COVID-19 outcomes; however, prolonged SARS-CoV-2 RNA shedding was observed. Risk factors for severe COVID-19 include the presence of two or more comorbidities and severe somatic disease.
- 17 January 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 21-31
Open AccessCOVID-19 in children with chronic digestive system pathology
COVID-19 in children is characterized by a predominance of mild and asymptomatic forms, along with frequent gastrointestinal symptoms. It is known that comorbid conditions are a risk factor for severe COVID-19 in children; however, the course of SARS-CoV-2 infection in children with chronic digestive system diseases remains under-researched. Objective. To identify the specific characteristics of COVID-19 in children with chronic digestive system diseases, assess risk factors for severe COVID-19, and evaluate the impact of immunosuppressive therapy on COVID-19 outcomes. Materials and Methods. A single-center cohort retrospective and prospective non-randomized study was conducted, including 74 patients with COVID-19 and chronic digestive system diseases and a control group of 30 patients with COVID-19 without comorbidities, all hospitalized in the infectious disease department of the Russian Children’s Clinical Hospital, Moscow, in 2022 and 2023. Results. Сhildren with underlying digestive system diseases were not at a higher risk of severe COVID-19 compared to the control group. Severe, uncontrolled somatic disease and the presence of two or more comorbidities were risk factors for complicated SARS-CoV-2 infection. The duration of detectable SARS-CoV-2 RNA in the study group was nine days. Conclusion. Patients with chronic digestive system diseases, including those receiving immunosuppressive therapy, do not appear to be at higher risk for severe or unfavorable COVID-19 outcomes; however, prolonged SARS-CoV-2 RNA shedding was observed. Risk factors for severe COVID-19 include the presence of two or more comorbidities and severe somatic disease.
- Open Access
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 22-28
COVID-19 in children with somatic pathology
The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 22-28
Open AccessCOVID-19 in children with somatic pathology
The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.
- Open Access
- 26 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 55-61
Visceral (hepatosplenic) form of bartonellosis
Висцеральная (печеночно-селезеночная) форма бартонеллеза
- 26 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 55-61
Open AccessVisceral (hepatosplenic) form of bartonellosis
Висцеральная (печеночно-селезеночная) форма бартонеллеза
- Open Access
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 44-48
Sparganosis
The urgency of the problem of sparganosis is due to the widespread prevalence of this disease in the wild, polymorphism of clinical manifestations and the possibility of severe damage to the orbits, central nervous system and internal organs. The purpose and result of the work is to summarize the data available in the literature on the etiology, epidemiology, clinical picture, diagnosis, treatment, and prevention of sparganosis. Conclusion. The causative agents of sparganosis are Spirometra decipiens, Spirometra erinaceieuropaei, Spirometra folium, Spirometra mansoni, and Sparganum proliferum. Allocate non-proliferative (peripheral, cerebral, spinal, ocular, visceral) and proliferative sparganosis. Diagnostics is carried out on the basis of a complex of clinical, instrumental, serological, molecular genetic studies. Surgical treatment is recommended: complete removal of the spargans
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 44-48
Open AccessSparganosis
The urgency of the problem of sparganosis is due to the widespread prevalence of this disease in the wild, polymorphism of clinical manifestations and the possibility of severe damage to the orbits, central nervous system and internal organs. The purpose and result of the work is to summarize the data available in the literature on the etiology, epidemiology, clinical picture, diagnosis, treatment, and prevention of sparganosis. Conclusion. The causative agents of sparganosis are Spirometra decipiens, Spirometra erinaceieuropaei, Spirometra folium, Spirometra mansoni, and Sparganum proliferum. Allocate non-proliferative (peripheral, cerebral, spinal, ocular, visceral) and proliferative sparganosis. Diagnostics is carried out on the basis of a complex of clinical, instrumental, serological, molecular genetic studies. Surgical treatment is recommended: complete removal of the spargans
- Open Access
- 5 October 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (3) , 66-70
A case of visceral leishmaniasis imported from Armenia
Случай висцерального лейшманиоза, завезенного из Армении
- 5 October 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (3) , 66-70
Open AccessA case of visceral leishmaniasis imported from Armenia
Случай висцерального лейшманиоза, завезенного из Армении
- Open Access
- 1 April 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (1) , 50-55
Cystic echinococcosis
Актуальность проблемы эхинококкозов человека обусловлена широкой распространенностью данного заболевания, полиморфизмом и тяжестью клинических проявлений. Целью работы является обобщение имеющихся в литературе данных об этиологии, эпидемиологии, клинике, диагностике, лечении, профилактике цистного эхинококкоза человека. Материалы и методы: проведен обзор отечественной и зарубежной литературы за последние 20 лет, в том числе, Интернет-ресурсов. Заключение. Возбудителями цистного эхинококкоза человека являются E. granulosus s.s., E. canadensis, E. ortleppi. Наиболее часто поражаются печень и легкие, реже — другие органы брюшной полости, кости, головной, спинной мозг, глаза и т.п. Диагностика осуществляется на основе комплекса клинических, инструментальных, серологических, молекулярно-генетических исследований. Лечение включает хирургическое удаление кист, чрескожные вмешательства и медикаментозную терапию.
- 1 April 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (1) , 50-55
Open AccessCystic echinococcosis
Актуальность проблемы эхинококкозов человека обусловлена широкой распространенностью данного заболевания, полиморфизмом и тяжестью клинических проявлений. Целью работы является обобщение имеющихся в литературе данных об этиологии, эпидемиологии, клинике, диагностике, лечении, профилактике цистного эхинококкоза человека. Материалы и методы: проведен обзор отечественной и зарубежной литературы за последние 20 лет, в том числе, Интернет-ресурсов. Заключение. Возбудителями цистного эхинококкоза человека являются E. granulosus s.s., E. canadensis, E. ortleppi. Наиболее часто поражаются печень и легкие, реже — другие органы брюшной полости, кости, головной, спинной мозг, глаза и т.п. Диагностика осуществляется на основе комплекса клинических, инструментальных, серологических, молекулярно-генетических исследований. Лечение включает хирургическое удаление кист, чрескожные вмешательства и медикаментозную терапию.